Literature DB >> 27995171

MicroRNA expression analysis in the liver of high fat diet-induced obese mice.

Won-Mo Yang1, Kyung-Ho Min1, Wan Lee2.   

Abstract

A previous study indicated a causal link between certain miRNAs induced by obesity and the development of hepatic insulin resistance and type 2 diabetes. Here we provide accompanying data collected using Affymetrix GeneChip miRNAs microarrays to identify the changes in miRNAs expression in the liver of mice fed a high fat diet (HFD). Differentially expressed microRNA analyses in the liver of the HFD-fed mice revealed a range of upregulated (>1.5-fold) or downregulated (<0.5-fold) miRNAs. Among those upregulated miRNAs, in silico target analysis, such as TargetScan, PicTar, and miRWalk, identified miRNAs with the putative binding sites on the 3'UTRs of INSR and/or IRS-1. Interpretation of the data and further extensive insights into the implication of miRNAs, particularly miR-15b, in hepatic insulin resistance can be found in "Obesity-induced miR-15b is linked causally to the development of insulin resistance through the repression of the insulin receptor in hepatocytes." (W.M. Yang, H.J. Jeong, S.W. Park, W. Lee, 2015)[1].

Entities:  

Keywords:  High fat diet; Liver; Mice; MicroRNAs; Obesity; Saturated fatty acids

Year:  2016        PMID: 27995171      PMCID: PMC5153443          DOI: 10.1016/j.dib.2016.11.081

Source DB:  PubMed          Journal:  Data Brief        ISSN: 2352-3409


Specifications Table Value of the data The data can allow a prediction of the biological significance of miRNAs associated with the pathogenesis of obesity, insulin resistance and type 2 diabetes. The data can be compared with miRNA analysis from other cell or tissue types with obesity. Differentially expressed miRNAs in this dataset could be applied to further study the changes in the cellular phenotype by high fat diet-induced obesity and metabolic diseases. The results support a previous study [1] and the use of transcriptomic technologies in non-model organisms.

Data

Diets rich in saturated fatty acids (SFA) can exacerbate obesity [2] and increase the risk of insulin resistance. This condition is characterized by an inadequate response of the insulin-sensitive tissues to insulin, leading to type 2 diabetes and metabolic syndrome [3]. Obesity modulates aberrantly the expression of certain miRNAs targeting the mRNAs of the insulin signaling molecules, and participates actively in the pathogenesis of insulin resistance [4], [5]. A previous study reported that a high fat diet (HFD) induces miR-15b in the liver of mice, which suppresses the expression of hepatic INSR, but not IRS-1, by targeting INSR 3’UTR directly [1]. Therefore, certain types of miRNA induced by obesity can be linked causally to the development of hepatic insulin resistance, which may in turn lead to type 2 diabetes. This study provides accompanying data collected using Affymetrix GeneChip microarrays to identify the changes in miRNA expression in the liver of mice fed with a HFD for 14 weeks. Differentially expressed miRNA analyses in the liver of HFD-fed mice showed that a range of miRNAs were upregulated more than 1.5-fold (Supplement File. 1) or downregulated less than 0.5-fold (Supplement File. 2). Among those differentially expressed miRNAs, the upregulated miRNAs may be involved in the reduction of INSR and IRS-1 levels observed in the liver of HFD-fed mice. Therefore, this study next examined whether the 3’UTRs of INSR and IRS-1 possess direct binding sites for the upregulated miRNAs. In silico target analysis using TargetScan, PicTar, and miRWalk showed that a range of certain miRNAs have putative binding sites for the 3’UTRs of INSR (Table 1) and/or IRS-1 (Table 2). An interpretation of the data and further extensive insights into the implication of miRNAs, particularly miR-15b, in hepatic insulin resistance can be found elsewhere [1].
Table 1

miRNAs putatively targeting INSR.

miRNAsFold changeAccessionSequence
miR-15b-5p1.62MIMAT0000124UAGCAGCACAUCAUGGUUUACA
miR-28a-5p1.58MIMAT0000653AAGGAGCUCACAGUCUAUUGAG
miR-28a-3p1.86MIMAT0004661CACUAGAUUGUGAGCUGCUGGA
miR-132-3p2.15MIMAT0000144UAACAGUCUACAGCCAUGGUCG
miR-140-3p1.73MIMAT0000152UACCACAGGGUAGAACCACGG
miR-149-5p16.27MIMAT0000159UCUGGCUCCGUGUCUUCACUCCC
miR-151-3p1.93MIMAT0000161CUAGACUGAGGCUCCUUGAGG
miR-181a-5p2.21MIMAT0000210AACAUUCAACGCUGUCGGUGAGU
miR-183-5p1.51MIMAT0000212UAUGGCACUGGUAGAAUUCACU
miR-193a-5p1.77MIMAT0004544UGGGUCUUUGCGGGCAAGAUGA
miR-212-3p3.23MIMAT0000659UAACAGUCUCCAGUCACGGCCA
miR-292b-5p2.83MIMAT0029864ACUCAAAACCUGGCGGCACUUUU
miR-296-3p1.78MIMAT0004576GAGGGUUGGGUGGAGGCUCUCC
miR-322-5p1.64MIMAT0000548CAGCAGCAAUUCAUGUUUUGGA
miR-326-3p2.04MIMAT0000559CCUCUGGGCCCUUCCUCCAGU
miR-330-3p2.35MIMAT0000569GCAAAGCACAGGGCCUGCAGAGA
miR-330-5p1.62MIMAT0004642UCUCUGGGCCUGUGUCUUAGGC
miR-342-3p1.50MIMAT0000590UCUCACACAGAAAUCGCACCCGU
miR-375-3p1.51MIMAT0000739UUUGUUCGUUCGGCUCGCGUGA
miR-376c-3p1.86MIMAT0003183AACAUAGAGGAAAUUUCACGU
miR-378a-3p1.54MIMAT0003151ACUGGACUUGGAGUCAGAAGG
miR-383-5p1.66MIMAT0000748AGAUCAGAAGGUGACUGUGGCU
miR-410-3p1.51MIMAT0001091AAUAUAACACAGAUGGCCUGU
miR-421-3p1.57MIMAT0004869AUCAACAGACAUUAAUUGGGCGC
miR-455-3p2.71MIMAT0003742GCAGUCCACGGGCAUAUACAC
miR-455-5p1.53MIMAT0003485UAUGUGCCUUUGGACUACAUCG
miR-532-3p3.81MIMAT0004781CCUCCCACACCCAAGGCUUGCA
miR-532-5p1.62MIMAT0002889CAUGCCUUGAGUGUAGGACCGU
miR-1224-5p3.40MIMAT0005460GUGAGGACUGGGGAGGUGGAG
Table 2

miRNAs putatively targeting IRS-1.

miRNAsFold changeAccessionSequence
miR-15b-5p1.62MIMAT0000124UAGCAGCACAUCAUGGUUUACA
miR-28a-3p1.86MIMAT0004661CACUAGAUUGUGAGCUGCUGGA
miR-92b-3p2.81MIMAT0004899UAUUGCACUCGUCCCGGCCUCC
miR-125a-5p2.15MIMAT0000135UCCCUGAGACCCUUUAACCUGUGA
miR-149-5p16.27MIMAT0000159UCUGGCUCCGUGUCUUCACUCCC
miR-151-5p1.66MIMAT0004536UCGAGGAGCUCACAGUCUAGU
miR-155-5p1.76MIMAT0000165UUAAUGCUAAUUGUGAUAGGGGU
miR-181a-5p2.21MIMAT0000210AACAUUCAACGCUGUCGGUGAGU
miR-181b-5p2.96MIMAT0000673AACAUUCAUUGCUGUCGGUGGGU
miR-181d-5p1.52MIMAT0004324AACAUUCAUUGUUGUCGGUGGGU
miR-183-5p1.51MIMAT0000212UAUGGCACUGGUAGAAUUCACU
miR-200c-3p1.51MIMAT0000657UAAUACUGCCGGGUAAUGAUGGA
miR-296-3p1.78MIMAT0004576GAGGGUUGGGUGGAGGCUCUCC
miR-322-5p1.64MIMAT0000548CAGCAGCAAUUCAUGUUUUGGA
miR-325-3p1.55MIMAT0004640UUUAUUGAGCACCUCCUAUCAA
miR-328-3p2.20MIMAT0000565CUGGCCCUCUCUGCCCUUCCGU
miR-330-3p2.35MIMAT0000569GCAAAGCACAGGGCCUGCAGAGA
miR-339-5p2.13MIMAT0000584UCCCUGUCCUCCAGGAGCUCACG
miR-340-5p1.54MIMAT0004651UUAUAAAGCAAUGAGACUGAUU
miR-342-3p1.50MIMAT0000590UCUCACACAGAAAUCGCACCCGU
miR-370-3p1.51MIMAT0001095GCCUGCUGGGGUGGAACCUGGU
miR-375-3p1.51MIMAT0000739UUUGUUCGUUCGGCUCGCGUGA
miR-376c-3p1.86MIMAT0003183AACAUAGAGGAAAUUUCACGU
miR-383-5p1.66MIMAT0000748AGAUCAGAAGGUGACUGUGGCU
miR-410-3p1.51MIMAT0001091AAUAUAACACAGAUGGCCUGU
miR-421-3p1.57MIMAT0004869AUCAACAGACAUUAAUUGGGCGC
miR-423-3p1.86MIMAT0003454AGCUCGGUCUGAGGCCCCUCAGU
miR-455-3p2.71MIMAT0003742GCAGUCCACGGGCAUAUACAC
miR-455-5p1.53MIMAT0003485UAUGUGCCUUUGGACUACAUCG
miR-466c-5p2.09MIMAT0004877UGAUGUGUGUGUGCAUGUACAUAU
miR-466i-5p1.78MIMAT0017325UGUGUGUGUGUGUGUGUGUG
miR-466m-5p1.78MIMAT0014882UGUGUGCAUGUGCAUGUGUGUAU
miR-500-3p2.29MIMAT0003507AAUGCACCUGGGCAAGGGUUCA
miR-501-3p1.73MIMAT0003509AAUGCACCCGGGCAAGGAUUUG
miR-532-5p1.62MIMAT0002889CAUGCCUUGAGUGUAGGACCGU
miR-669a-5p2.31MIMAT0003477AGUUGUGUGUGCAUGUUCAUGUCU
miR-669f-5p1.87MIMAT0017327AGUUGUGUGUGCAUGUGCAUGUGU
miR-669k-5p1.85MIMAT0017323UGUGCAUGUGUGUAUAGUUGUGUGC
miR-669l-5p1.87MIMAT0009418AGUUGUGUGUGCAUGUAUAUGU
miR-669m-5p1.78MIMAT0017346UGUGUGCAUGUGCAUGUGUGUAU
miR-669p-5p2.31MIMAT0014889AGUUGUGUGUGCAUGUUCAUGUCU
miR-1197-3p1.51MIMAT0005858UAGGACACAUGGUCUACUUCU
miR-3102-5p1.79MIMAT0014933GUGAGUGGCCAGGGUGGGGCUG
miR-3102-5p.2-5p1.88MIMAT0014934GGUGGUGCAGGCAGGAGAGCC
miR-3473a1.77MIMAT0015645UGGAGAGAUGGCUCAGCA
miR-3473b1.71MIMAT0020367GGGCUGGAGAGAUGGCUCAG
miR-3473d2.35MIMAT0020632CCACUGAGCCACUUUCCAGCCCUU

Experimental design, materials and methods

Animals and high fat diet (HFD)-induced obesity

All The Animal Use and Care Committee at Dongguk University approved all experimental procedures involving mice. The C57BL/6N male mice were purchased from OrientBio (Seongnam, Gyeonggi, Korea). They were maintained in a temperature (20–22 °C) and humidity (55±10%) controlled facility with a 12:12 h light–dark cycle and given access to food and water ad libitum. At 6 weeks of age, the mice were fed either a normal fat diet (NFD, 12.4% calories from fat; Purina, Wilkes-Barre, PA, USA) or a HFD (60% calories from fat; Dyets Inc., Bethlehem, PA, USA) for 14 weeks. During the experimental period, the body weights of the mice were recorded weekly. At the end of the experiment, mice were fasted for 12 h and sacrificed by a cervical dislocation. The liver was removed rapidly, washed with cold PBS, and subjected to RNA extraction.

RNA extraction and quality check

The total RNA from the liver of mice was extracted using a miRNeasy Mini Kit (Qiagen) according to the manufacturer׳s instructions. The purity and integrity of the RNA extracted were assessed using a ND-1000 Spectrophotometer (NanoDrop) and Agilent 2100 Bioanalyzer (Agilent Technologies). Equal amounts of RNA from five mice were combined and used for the microarray.

miRNA arrays analysis

The total RNA from the liver of the mice described above was prepared and subjected to the Affymetrix Genechip miRNA 4.0 array (Affymetrix) process according to the Affymetrix technical instructions. Briefly, 600ng of RNA was labeled with a FlashTag™ Biotin RNA Labeling Kit (Genisphere, Hatfield, PA, USA). The labeled RNA was quantified, fractionated, and hybridized to the miRNA microarray provided by the manufacture. The labeled RNA was heated to 99 °C for 5 min and incubated to 45 °C for 5 min. RNA-array hybridization was conducted with agitation at 60 rpm for 16 h at 48 °C on an Affymetrix® 450 Fluidics Station. The chips were stained using a Genechip Fluidics Station 450 (Affymetrix), and scanned with an Affymetrix GCS 3000 scanner (Affymetrix). All signals were normalized using the quantile method after a log2 transformation to make them comparable across the microarrays.

Data extraction and in silico analysis

Differentially expressed miRNAs were analyzed automatically using Affymetrix® GeneChip™ Command Console software according to the Affymetrix data extraction protocol and identified by calculating the fold change of either a NFD-fed mice versus a HFD-fed mice. The differentially expressed miRNAs putatively targeting INSR 3’UTR and IRS-1 3’UTR were screened computationally using publicly available algorithms (TargetScan: www.targetscan.org, Pictar: pictar.mdc-berlin.de, and miRWalk: www.umm.uni-heidelberg.de).
Subject areaBiology, Biochemistry
More specific subject areaObesity, Metabolism, MicroRNA
Type of dataTables and Excel files
How data was acquiredAffymetrix GeneChip microarray analyses of miRNAs
Data formatAnalyzed
Experimental factorsDiet-induced obesity, RNA Isolation, Affymetrix Genechip miRNA microarray, In silico analysis of miRNAs
Experimental featuresDifferentially expressed miRNAs of the liver of mice fed with either a NFD or a HFD were analyzed using Affymetrix GeneChip miRNA microarray.
Data source locationDongguk University School of Medicine, Gyeongju 780-714, Korea
Data accessibilityThe data are available with this article
  5 in total

1.  Obesity-induced miR-15b is linked causally to the development of insulin resistance through the repression of the insulin receptor in hepatocytes.

Authors:  Won-Mo Yang; Hyo-Jin Jeong; Se-Whan Park; Wan Lee
Journal:  Mol Nutr Food Res       Date:  2015-08-12       Impact factor: 5.914

Review 2.  Mechanisms linking obesity to insulin resistance and type 2 diabetes.

Authors:  Steven E Kahn; Rebecca L Hull; Kristina M Utzschneider
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

Review 3.  Molecular medicine of microRNAs: structure, function and implications for diabetes.

Authors:  Erica Hennessy; Lorraine O'Driscoll
Journal:  Expert Rev Mol Med       Date:  2008-08-15       Impact factor: 5.600

Review 4.  The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes.

Authors:  Rachel J Perry; Varman T Samuel; Kitt F Petersen; Gerald I Shulman
Journal:  Nature       Date:  2014-06-05       Impact factor: 49.962

Review 5.  Implications of microRNAs in the pathogenesis of diabetes.

Authors:  Seung-Yoon Park; Hyo-Jin Jeong; Won-Mo Yang; Wan Lee
Journal:  Arch Pharm Res       Date:  2013-01-30       Impact factor: 4.946

  5 in total
  2 in total

Review 1.  NutrimiRAging: Micromanaging Nutrient Sensing Pathways through Nutrition to Promote Healthy Aging.

Authors:  Víctor Micó; Laura Berninches; Javier Tapia; Lidia Daimiel
Journal:  Int J Mol Sci       Date:  2017-04-26       Impact factor: 5.923

2.  MiR-183-5p Induced by Saturated Fatty Acids Hinders Insulin Signaling by Downregulating IRS-1 in Hepatocytes.

Authors:  Mai Thi Nguyen; Kyung-Ho Min; Wan Lee
Journal:  Int J Mol Sci       Date:  2022-03-10       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.